Chiffre d'affaires—
Marge EBIT—
Résultat net€342k
Fonds de roulement€-1k
Cycle de vie & signaux d'insolvabilité
0 événements du Moniteur belge
Aucun signal d'insolvabilité au Moniteur belge
Moniteur belge — actes
6 actes Évolution du capital · 4
06-12-2024
Modification du capital
10-06-2024
Modification du capital
25-01-2023
Modification du capital
28-09-2022
Modification du capital
Tous les actes · 6
mis à jour il y a 1 an
2024
06-12-2024 Restructuration des classes d'actions
Notaire:
David REMY · Fernelmont
Détails techniques
{
"events": [
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"subscribers": [
{
"kbo": "0538.839.354",
"rrn": null,
"kind": "org",
"name": "SPREDS FINANCE",
"share_class": "B1",
"liberation_pct": 100.0,
"contribution_kind": "geld",
"n_shares_subscribed": 74500,
"contribution_amount_eur": 74500.0
}
],
"share_emission": {
"agio_eur": 0.0,
"share_form": "no_nominal_value",
"share_class": "B1",
"n_new_shares": 74500,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 1.0
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_conversion",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"subscribers": [
{
"kbo": null,
"rrn": null,
"kind": "person",
"name": "Pascal VAN HOVE",
"share_class": null,
"liberation_pct": null,
"contribution_kind": null,
"n_shares_subscribed": null,
"contribution_amount_eur": null
}
],
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "David REMY",
"firm_city": null,
"firm_name": null,
"office_city": "Fernelmont",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2024-12-06",
"filing_date": "2024-12-03",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "assembl\u00E9e_g\u00E9n\u00E9rale_extraordinaire",
"act_date": "2024-08-08",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0783.494.239",
"name_full": "YNIOS Pharma",
"legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [],
"shareholders_after": [
{
"kbo": "0538.839.354",
"pct": null,
"kind": "org",
"name": "SPREDS FINANCE",
"role": "aandeelhouder",
"n_shares": 74500,
"share_class": "B1"
},
{
"kbo": null,
"pct": null,
"kind": "person",
"name": "Pascal VAN HOVE",
"role": "aandeelhouder",
"n_shares": 87400,
"share_class": "B2"
}
],
"share_classes_after": [
{
"n_shares": 5370000,
"class_name": "A",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 187100,
"class_name": "B1",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 300000,
"class_name": "B2",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 2700,
"class_name": "B3",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 200000,
"class_name": "B4",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
}
]
}06-12-2024 Modification des statuts — traduction des statuts, coordination des statuts et modification d'articles spécifiques
Notaire:
David REMY · Fernelmont
Détails techniques
{
"notary": {
"name": "David REMY",
"firm_city": null,
"firm_name": null,
"office_city": "Fernelmont",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2024-12-06",
"filing_date": "2024-12-03",
"act_kind_objet": "STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS), CAPITAL, ACTIONS, DIVERS"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2024-08-08",
"unanimous": null
},
"statute_change": {
"kinds": [
"translation",
"coordination",
"targeted_amendment"
],
"scope": "full_restatement",
"trigger": "wvv_adaptation",
"language_after": "fr",
"language_before": "fr"
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0783.494.239",
"name_full_after": "YNIOS Pharma",
"legal_form_after": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e",
"name_full_before": "YNIOS Pharma",
"current_zetel_raw": "Chemin de l\u2019Yerne, 6C 4537 Verlaine",
"legal_form_before": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e"
},
"special_mandates": [
{
"holder_kbo": null,
"holder_name": "David REMY",
"scope_categories": [
"publication"
],
"with_substitution": true
}
],
"articles_modified": [
{
"summary": "Remplace le texte de l\u0027article 5 des statuts par un nouveau texte d\u00E9taillant l\u0027\u00E9mission et la r\u00E9partition des actions en cinq cat\u00E9gories.",
"new_text": "Article 5. Apports\nEn r\u00E9mun\u00E9ration des apports, 6.059.800 actions ont \u00E9t\u00E9 \u00E9mises, r\u00E9parties en 5 cat\u00E9gories :\n \u2022 5.370.000 actions de cat\u00E9gorie A (FONDATEURS) ;\n \u2022 187.100 actions de cat\u00E9gorie B1 (SPREDS FINANCE Tax Shelter) ;\n \u2022 300.000 actions de cat\u00E9gorie B2 (PRIVES Tax Shelter) ;\n \u2022 2.700 actions de cat\u00E9gorie B3 (SPREDS FINANCE Normal) ;\n \u2022 200.000 actions de cat\u00E9gorie B4 (PRIVES Normal).\nChaq",
"change_kind": "replaced",
"article_title": "Apports",
"article_number": "5"
}
],
"governance_change": null,
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "David REMY",
"org_rep_person_name": null
},
"co_filed_documents": [],
"shareholder_rights": {
"quorum_rules_changed": false,
"liquidation_preference_text": null,
"voorkeurrecht_rules_changed": true,
"aandelenoverdracht_restrictions_changed": false
},
"voorwerp_change_summary": null,
"capital_structure_change": {
"operations": [
"share_class_creation"
],
"split_ratio": null,
"shares_after": null,
"shares_before": null,
"capital_after_eur": null,
"capital_before_eur": null,
"share_classes_after": [
{
"count": 74500,
"label": "B1",
"rights_summary": "Souscription nouvelle, r\u00E9gime Tax Shelter",
"voting_per_share": null
},
{
"count": 300000,
"label": "B2",
"rights_summary": "PRIVES Tax Shelter",
"voting_per_share": null
},
{
"count": 2700,
"label": "B3",
"rights_summary": "SPREDS FINANCE Normal",
"voting_per_share": null
},
{
"count": 200000,
"label": "B4",
"rights_summary": "PRIVES Normal",
"voting_per_share": null
}
]
},
"coordinated_text_lineage": null
}10-06-2024 Publication au Moniteur belge — Divers
Résumé:
Conversion legal formNotaire:
David REMY · Fernelmont
Détails techniques
{
"stage": null,
"notary": {
"name": "David REMY",
"firm_city": null,
"firm_name": null,
"office_city": "Fernelmont",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2024-06-10",
"filing_date": "2024-06-06",
"act_kind_objet": "STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS), CAPITAL, ACTIONS, DIVERS"
},
"decision": {
"body": "algemene_vergadering",
"act_date": "2024-03-19",
"unanimous": null
},
"conversion": {
"effective_date": null,
"jurisdiction_to": null,
"legal_form_after": null,
"jurisdiction_from": null,
"legal_form_before": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e"
},
"detected_kind": "conversion_legal_form",
"report_waiver": {
"summary": "The shareholders waived their preferential subscription right under article 7 of the statutes.",
"articles": [
"7"
]
},
"restructuring": {
"parties": [
{
"kbo": "0783.494.239",
"name": "YNIOS Pharma",
"role": "contributor",
"address": "Chemin de l\u2019Yerne, 6C, 4537 Verlaine",
"is_foreign": false,
"legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e",
"is_new_company": false,
"jurisdiction_country": null
},
{
"kbo": "0538.839.354",
"name": "SPREDS FINANCE",
"role": "contributor",
"address": null,
"is_foreign": false,
"legal_form": "soci\u00E9t\u00E9 anonyme",
"is_new_company": false,
"jurisdiction_country": null
},
{
"kbo": null,
"name": "Pascal VAN HOOVE",
"role": "contributor",
"address": null,
"is_foreign": false,
"legal_form": null,
"is_new_company": false,
"jurisdiction_country": null
},
{
"kbo": null,
"name": "Ilse DE GROOTE",
"role": "contributor",
"address": null,
"is_foreign": false,
"legal_form": null,
"is_new_company": false,
"jurisdiction_country": null
}
],
"exchange_ratio": null,
"legal_articles": [
"7"
],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": null,
"exchange_ratio_text": null,
"new_shares_issued_n": 5985300,
"real_estate_included": false,
"patrimony_description": null,
"equity_transferred_eur": null,
"accounting_effective_date": null
},
"subject_company": {
"kbo": "0783.494.239",
"name_full": "YNIOS Pharma",
"legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "David REMY",
"org_rep_person_name": null
},
"summary_narrative": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire de YNIOS Pharma a pris des r\u00E9solutions pour augmenter le nombre d\u0027actions, cr\u00E9er de nouvelles cat\u00E9gories d\u0027actions et souscrire \u00E0 ces nouvelles actions aupr\u00E8s de partenaires certifi\u00E9s et d\u0027investisseurs priv\u00E9s. Parall\u00E8lement, les statuts ont \u00E9t\u00E9 modifi\u00E9s pour refl\u00E9ter ces apports.",
"co_filed_documents": [],
"detected_real_type": "other",
"referenced_correction": {
"prior_pub_date": "2022-03-18",
"what_corrected": null,
"prior_pub_number": "22318105"
},
"should_reroute_to_category": null
}10-06-2024 Restructuration des classes d'actions
Notaire:
David REMY · Fernelmont
Détails techniques
{
"events": [
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"subscribers": [
{
"kbo": "0538.839.354",
"rrn": null,
"kind": "org",
"name": "SPREDS FINANCE",
"share_class": "B1",
"liberation_pct": 100.0,
"contribution_kind": null,
"n_shares_subscribed": 7600,
"contribution_amount_eur": null
}
],
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": "B1",
"n_new_shares": 7600,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"subscribers": [
{
"kbo": "0538.839.354",
"rrn": null,
"kind": "org",
"name": "SPREDS FINANCE",
"share_class": "B2",
"liberation_pct": 100.0,
"contribution_kind": null,
"n_shares_subscribed": 87400,
"contribution_amount_eur": null
}
],
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": "B2",
"n_new_shares": 87400,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": 87400,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"subscribers": [
{
"kbo": "0538.839.354",
"rrn": null,
"kind": "org",
"name": "SPREDS FINANCE",
"share_class": "B3",
"liberation_pct": 100.0,
"contribution_kind": null,
"n_shares_subscribed": 2700,
"contribution_amount_eur": null
}
],
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": "B3",
"n_new_shares": 2700,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": 2700,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"subscribers": [
{
"kbo": null,
"rrn": null,
"kind": "person",
"name": "Pascal VAN HOOVE",
"share_class": "B4",
"liberation_pct": 100.0,
"contribution_kind": null,
"n_shares_subscribed": 87600,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "person",
"name": "Ilse DE GROOTE",
"share_class": "B4",
"liberation_pct": 100.0,
"contribution_kind": null,
"n_shares_subscribed": 25000,
"contribution_amount_eur": null
}
],
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": "B4",
"n_new_shares": 112600,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": 112600,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "David REMY",
"firm_city": null,
"firm_name": null,
"office_city": "Fernelmont",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2024-06-10",
"filing_date": "2024-06-06",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "assembl\u00E9e_generale_extraordinaire",
"act_date": "2024-03-19",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0783.494.239",
"name_full": "YNIOS Pharma",
"legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [],
"shareholders_after": [
{
"kbo": "0538.839.354",
"pct": null,
"kind": "org",
"name": "SPREDS FINANCE",
"role": null,
"n_shares": 5370000,
"share_class": "A"
},
{
"kbo": "0538.839.354",
"pct": null,
"kind": "org",
"name": "SPREDS FINANCE",
"role": null,
"n_shares": 112600,
"share_class": "B1"
},
{
"kbo": "0538.839.354",
"pct": null,
"kind": "org",
"name": "SPREDS FINANCE",
"role": null,
"n_shares": 387400,
"share_class": "B2"
},
{
"kbo": "0538.839.354",
"pct": null,
"kind": "org",
"name": "SPREDS FINANCE",
"role": null,
"n_shares": 2700,
"share_class": "B3"
},
{
"kbo": null,
"pct": null,
"kind": "person",
"name": "Pascal VAN HOOVE",
"role": null,
"n_shares": 87600,
"share_class": "B4"
},
{
"kbo": null,
"pct": null,
"kind": "person",
"name": "Ilse DE GROOTE",
"role": null,
"n_shares": 25000,
"share_class": "B4"
}
],
"share_classes_after": [
{
"n_shares": 5370000,
"class_name": "A",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 112600,
"class_name": "B1",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 387400,
"class_name": "B2",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 2700,
"class_name": "B3",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 112600,
"class_name": "B4",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
}
]
}2023
25-01-2023 Restructuration des classes d'actions
Notaire:
David REMY · Fernelmont
Détails techniques
{
"events": [
{
"kind": "share_class_conversion",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": 5575000,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": 200000.0,
"before_eur": null,
"subscribers": [
{
"kbo": null,
"rrn": null,
"kind": "person",
"name": "PASCAL VAN HOVE",
"share_class": "B2",
"liberation_pct": 100.0,
"contribution_kind": "geld",
"n_shares_subscribed": 100000,
"contribution_amount_eur": 100000.0
},
{
"kbo": null,
"rrn": null,
"kind": "person",
"name": "Madame DE GROOTE Ilse Leonce",
"share_class": "B2",
"liberation_pct": 100.0,
"contribution_kind": "geld",
"n_shares_subscribed": 100000,
"contribution_amount_eur": 100000.0
}
],
"share_emission": {
"agio_eur": 0.0,
"share_form": null,
"share_class": "B2",
"n_new_shares": 200000,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 1.0
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": 200000.0,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "statutory_reserve_release",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": "convert_to_apports_non_appeles"
},
{
"kind": "other",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "David REMY",
"firm_city": null,
"firm_name": null,
"office_city": "Fernelmont",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2023-01-25",
"filing_date": "2023-01-23",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "assembl\u00E9e g\u00E9n\u00E9rale extraordinaire",
"act_date": "2023-01-17",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0783.494.239",
"name_full": "YNIOS Pharma",
"legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [],
"shareholders_after": [],
"share_classes_after": [
{
"n_shares": 5370000,
"class_name": "A",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 105000,
"class_name": "B1",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 300000,
"class_name": "B2",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
}
]
}2022
28-09-2022 Restructuration des classes d'actions
Notaire:
David REMY · Fernelmont
Détails techniques
{
"events": [
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_transfer",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"subscribers": [
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "SPREDS FINANCE",
"share_class": "B1",
"liberation_pct": 100.0,
"contribution_kind": "geld",
"n_shares_subscribed": 105000,
"contribution_amount_eur": 105000.0
},
{
"kbo": null,
"rrn": null,
"kind": "person",
"name": "VAN HOVE Pascal Urbain",
"share_class": "B2",
"liberation_pct": 100.0,
"contribution_kind": "geld",
"n_shares_subscribed": 100000,
"contribution_amount_eur": 100000.0
}
],
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "statutory_reserve_release",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": "convert_to_distributable"
}
],
"notary": {
"name": "David REMY",
"firm_city": null,
"firm_name": null,
"office_city": "Fernelmont",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2022-09-28",
"filing_date": "2022-09-26",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "assembl\u00E9e_generale_extraordinaire",
"act_date": "2022-09-06",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0783.494.239",
"name_full": "YNIOS Pharma",
"legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Ghislaine",
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [],
"shareholders_after": [
{
"kbo": "0783.494.239",
"pct": null,
"kind": "org",
"name": "YNIOS Pharma",
"role": "aandeelhouder",
"n_shares": 5370000,
"share_class": "A"
},
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "SPREDS FINANCE",
"role": "aandeelhouder",
"n_shares": 105000,
"share_class": "B1"
},
{
"kbo": null,
"pct": null,
"kind": "person",
"name": "VAN HOVE Pascal Urbain",
"role": "aandeelhouder",
"n_shares": 100000,
"share_class": "B2"
}
],
"share_classes_after": [
{
"n_shares": 5370000,
"class_name": "A",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 105000,
"class_name": "B1",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 100000,
"class_name": "B2",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
}
]
}